医学
索拉非尼
肝细胞癌
内科学
肿瘤科
临床试验
随机对照试验
瑞戈非尼
作者
Timothy J Brown,Arjun Gupta,Ramy Sedhom,Thomas Benjamin Karasic,Mark Yarchoan
标识
DOI:10.1200/jco.2021.39.3_suppl.327
摘要
327Background: Sorafenib was first approved by the US FDA to treat patients with advanced hepatocellular carcinoma (HCC) after two landmark trials (SHARP and Asia-Pacific) showed improved overall s...
科研通智能强力驱动
Strongly Powered by AbleSci AI